Research and Development

Showing 15 posts of 9600 posts found.

jonas_jeffery_5x7_300dpi_srgb

Jeff Jonas joins Shire’s Leadership Team

November 15, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire

Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …

UK Board appointments at Universal WorldEvents

November 15, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Healthcare events firm Universal WorldEvents has appointed Denise Abbott and Nicola Burns to its Board. Abbott (pictured) joined Universal WorldEvents …
eugene_washington-iha-005108

Eugene Washington appointed to J&J Board of directors

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …

AstraZeneca signs genome deal

November 13, 2012 Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …
coulthard

NHS Commissioning Board appoints Patients and Information directors

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …
kb

Pharma can help NHS transition, says partnership leader

November 13, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT

A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …
Pfizer image

Pfizer and GSK end agreements

November 12, 2012 Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …

Contract research news in brief

November 12, 2012 Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River

Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.
board_peter_chambre

immatics appoints Peter Chambré as chairman

November 12, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
stephen whitehead image

Pharma treated as though ‘selling cyanide’

November 9, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …
janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012 Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …
bad pharma image

Goldacre is right – greater honesty is needed

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …
screen_shot_2012-11-07_at_10

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …
The Gateway to Local Adoption Series

Latest content